Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71.5Revenue (TTM) $M20.2Net Margin (%)-74.4Altman Z-Score-15.0
Enterprise Value $M45.5EPS (TTM) $-0.2Operating Margin %-59.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score9.7Pre-tax Margin (%)-73.9Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %--Quick Ratio6.1Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %--Current Ratio6.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-106.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M75.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVEOSeth Klarman 2014-12-31 Sold Out -0.07%$0.65 - $1.17
($0.91)
$ 0.954%Sold Out0
AVEOGeorge Soros 2014-09-30 Sold Out $1.09 - $1.79
($1.26)
$ 0.95-25%Sold Out0
AVEOGeorge Soros 2014-06-30 Buy $1.02 - $1.72
($1.29)
$ 0.95-26%New holding49,076
AVEOSeth Klarman 2013-06-30 Reduce-0.26%$2.34 - $8.27
($4.27)
$ 0.95-78%Reduce -21.90%3,829,350
AVEOGeorge Soros 2011-12-31 Sold Out -0.0031%$14.53 - $17.35
($8.42)
$ 0.95-89%Sold Out0
AVEOSeth Klarman 2011-09-30 Add0.29%$15.12 - $20.77
($17.66)
$ 0.95-95%Add 12.79%5,000,000
AVEOGeorge Soros 2011-09-30 Reduce-0.04%$15.12 - $20.77
($17.66)
$ 0.95-95%Reduce -92.80%11,600
AVEOSeth Klarman 2011-06-30 Add0.78%$13.06 - $20.66
($16.79)
$ 0.95-94%Add 25.76%4,433,010
AVEOGeorge Soros 2011-06-30 Buy 0.05%$13.06 - $20.66
($16.79)
$ 0.95-94%New holding161,000
AVEOSeth Klarman 2011-03-31 Add1.15%$13.15 - $15.02
($14.21)
$ 0.95-93%Add 76.25%3,525,000
AVEOSeth Klarman 2010-12-31 Buy 1.68%$13.84 - $17.41
($15.14)
$ 0.95-94%New holding2,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVEO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dallas Matthew DVP, Finance 2015-01-16Sell3,075$0.8215.85view
Gyuris JenoSVP, Chief Scientific Officer 2015-01-07Sell4,484$0.818.75view
Vittiglio JosephSVP, General Counsel 2015-01-07Sell4,484$0.818.75view
Dallas Matthew DVP, Finance 2015-01-07Sell519$0.818.75view
BAILEY MICHAEL PPresident & CEO 2015-01-07Sell4,484$0.818.75view
Dallas Matthew DVP, Finance 2014-07-01Sell0$018.75view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-42.07view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-42.07view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-42.07view
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-42.07view

Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
    Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
    Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
    Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
    Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
    AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
    Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
    Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

    More From Other Websites
    The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen Aug 18 2016
    Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data Aug 17 2016
    Bristol-Myers Squibb (BMY) Stock Falls, Bernstein: Failed Trial Impact to Persist Aug 15 2016
    AVEO Initiates the Evaluation of Tivozanib in Combination with Bristol-Myers Squibb’s Opdivo®... Aug 15 2016
    AVEO Initiates the Evaluation of Tivozanib in Combination with Bristol-Myers Squibb’s Opdivo®... Aug 15 2016
    AVEO PHARMACEUTICALS INC Financials Aug 13 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : August 11, 2016 Aug 11 2016
    AVEO Pharmaceuticals, Inc. :AVEO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 Aug 09 2016
    AVEO (AVEO) Reports a Wider Loss in Q2, Tivozanib in Focus Aug 05 2016
    AVEO (AVEO) Reports Narrower-than-Expected Loss in Q2 Aug 04 2016
    AVEO reports 2Q loss Aug 04 2016
    AVEO reports 2Q loss Aug 04 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 04 2016
    AVEO Oncology Reports Second Quarter 2016 Financial Results and Provides Business Update Aug 04 2016
    AVEO Oncology Reports Second Quarter 2016 Financial Results and Provides Business Update Aug 04 2016
    AVEO PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 04 2016
    Will AVEO (AVEO) Pull a Surprise This Earnings Season? Aug 03 2016
    AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4% Jul 22 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : July 19, 2016 Jul 19 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : July 6, 2016 Jul 06 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)